Kandice Roush

1.6k total citations · 1 hit paper
5 papers, 612 citations indexed

About

Kandice Roush is a scholar working on Molecular Biology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Kandice Roush has authored 5 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Genetics and 1 paper in Cardiology and Cardiovascular Medicine. Recurrent topics in Kandice Roush's work include Muscle Physiology and Disorders (5 papers), Virus-based gene therapy research (2 papers) and Advanced biosensing and bioanalysis techniques (2 papers). Kandice Roush is often cited by papers focused on Muscle Physiology and Disorders (5 papers), Virus-based gene therapy research (2 papers) and Advanced biosensing and bioanalysis techniques (2 papers). Kandice Roush collaborates with scholars based in United States. Kandice Roush's co-authors include Robert B. Weiss, Natalie Street, Nancy D. Leslie, Cindy Hamil, Chris Shilling, Roula Al‐Dahhak, Jerry R. Mendell, Diane M. Dunn, Kevin M. Flanigan and Maha Mahmoud and has published in prestigious journals such as Neurology, Annals of Neurology and Neuromuscular Disorders.

In The Last Decade

Kandice Roush

5 papers receiving 606 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evidence‐based path to newborn screening for duchenne muscular dystrophy

2012 607 citations Jerry R. Mendell, Chris Shilling et al. Annals of Neurology profile →

Peers

Countries citing papers authored by Kandice Roush

Since Specialization

Citations

This map shows the geographic impact of Kandice Roush's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kandice Roush with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kandice Roush more than expected).

Fields of papers citing papers by Kandice Roush

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kandice Roush. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kandice Roush. The network helps show where Kandice Roush may publish in the future.

Co-authorship network of co-authors of Kandice Roush

This figure shows the co-authorship network connecting the top 25 collaborators of Kandice Roush. A scholar is included among the top collaborators of Kandice Roush based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kandice Roush. Kandice Roush is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

#	Work	Indexed citations
1	PP09.16 – 2691: Eteplirsen, a phosphorodiamidate morpholino oligomer (PMO) for the treatment of Duchenne muscular dystrophy (DMD): 3.2 year update on six-minute walk test (6MWT), pulmonary function testing (PFT), and safety 2015 ·European Journal of Paediatric Neurology ·Edward M. Kaye, J. Mendell, (unknown), Zarife Sahenk, Kandice Roush, Linda Lowes, (unknown), (unknown), Vishwas Malik, (unknown), Christopher Shilling, Petra W. Duda, Jay Saoud	2
2	Results at 96 Weeks of a Phase IIb Extension Study of the Exon-Skipping Drug Eteplirsen in Patients with Duchenne Muscular Dystrophy (DMD) (S6.002) 2014 ·Neurology ·Edward M. Kaye, Jerry R. Mendell, Louise R. Rodino‐Klapac, Zarife Sahenk, Kandice Roush, Loren Bird, Linda Lowes, Lindsay N. Alfano, (unknown), Sarah Lewis, Vinod Malik, Kim Shontz, Christopher Shilling, Peter Sazani, Jihad B. Saoud	1
3	P.11.20 Results at 2 years of a phase IIb extension study of the exon-skipping drug eteplirsen in patients with DMD 2013 ·Neuromuscular Disorders ·J. Mendell, Louise R. Rodino‐Klapac, Zarife Sahenk, Kandice Roush, Loren Bird, Linda Lowes, Lindsay N. Alfano, (unknown), Sarah Lewis, (unknown), Kim Shontz, (unknown), John R. Kean, Hugh D. Allen, Christopher Shilling, Peter Sazani, Jihad B. Saoud, Edward M. Kaye	1
4	Evidence‐based path to newborn screening for duchenne muscular dystrophy breakdown → 2012 ·Annals of Neurology ·Jerry R. Mendell, Chris Shilling, Nancy D. Leslie, Kevin M. Flanigan, Roula Al‐Dahhak, (unknown), (unknown), Diane M. Dunn, Brett Duval, (unknown), Cindy Hamil, Maha Mahmoud, Kandice Roush, (unknown), (unknown), (unknown), Natalie Street, (unknown), Robert B. Weiss	607
5	D.O.1 A two-tiered approach to newborn screening for Duchenne muscular dystrophy (DMD) using dried blood spots for sequential CK and DNA analysis 2012 ·Neuromuscular Disorders ·J. Mendell, Christopher Shilling, N. Leslie, Kevin M. Flanigan, Roula Al‐Dahhak, Julie M. Gastier‐Foster, (unknown), Diane M. Dunn, Brett Duval, (unknown), Cindy Hamil, (unknown), Kandice Roush, Loren Bird, (unknown), Robert B. Weiss	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact